Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 5.30%, EPS grew 80.0% and free cash flow fell 12.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow PGNY
Progyny, Inc. (PGNY) EV/Sales
As of 16 October 2026, Progyny, Inc. (PGNY) trades at a EV/Sales of 1.4×. Over the past ten years it has ranged from 0.6× (October 2019) to 14.4× (June 2021); the current reading is higher than 24% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | 26.63% |
| FY2024 | 1.2× | (60.13%) |
| FY2023 | 2.9× | (13.07%) |
| FY2022 | 3.3× | (61.65%) |
| FY2021 | 8.7× | (14.67%) |
| FY2020 | 10.2× | 376.26% |
| FY2019 | 2.1× | 255.70% |
| FY2018 | 0.6× | 0.00% |
| FY2017 | 0.6× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | 72.84% |
| Mar 2026 | 0.9× | (39.30%) |
| Dec 2025 | 1.5× | 23.45% |
| Sep 2025 | 1.2× | (6.79%) |
| 27 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CNC Centene Corporation compare | 0.1× |
| MOH Molina Healthcare, Inc compare | 0.1× |
| HUM Humana Inc. compare | 0.3× |
| ALHC Alignment Healthcare, Inc. compare | 0.3× |
| CI Cigna Group compare | 0.4× |
| OSCR Oscar Health, Inc. compare | 0.4× |
| ELV Elevance Health, Inc. compare | 0.4× |
| CLOV Clover Health Investments, Corp. compare | 0.9× |
| PGNY Progyny, Inc. | 1.4× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)